Mycoplasma hominis lipid-associated membrane protein antigens for effective detection of M. hominis-specific antibodies in humans

Clinical Infectious Diseases

Volumn 36, Issue 10, 2003, Pages 1246-1253

  Lo, Shyh Ching ^a   Wang, Richard Y H ^c   Grandinetti, Teresa ^b   Zou, Nianxiang ^a   Haley, Christine L D ^a   Hayes, Michael M ^a   Wear, Douglas J ^a   Shih, James W K ^c  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b National Capital Chapter   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPID ASSOCIATED MEMBRANE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA HOMINIS; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SPECIES DIFFERENCE; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPID METABOLISM; MALE; MEMBRANE PROTEINS; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0037508536     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374851     Document Type: Article

References (22)

1. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62:1094-156.
2. Christiansen G. Genetics variation in natural populations. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, eds. Mycoplasmas: molecular biology, and pathogenesis. Washington, DC: American Society for Microbiology, 1992:561-73.
3. Wise KS. Adaptive surface variation in mycoplasmas. Trends Microbiol 1993; 1:59-63.
4. Yogev D, Browning GF, Wise KS. Genetic mechanisms of surface variation. In: Razin S, Herrmann R, eds. Molecular biology and pathogenicity of mycoplasmas. New York: Kluwer Academic/Plenum, 2002:417-44.
5. Barile MF, Grabowski MW, Stephens EB, et al. Mycoplasma hominis-tissue cell interactions: a review with new observations on phenotypic and genotypic properties. Sex Transm Dis 1983; 10(Suppl 4):345-54.
6. Blanchard A, Bebear CM. Mycoplasmas of humans. In: Razin S, Herrmann R, eds. Molecular biology and pathogenicity of mycoplasmas. New York: Kluwer Academic/Plenum, 2002:45-71.
7. Cassell GH, Cole BC. Mycoplasmas as agents of human disease. N Engl J Med 1981; 304:80-9.
8. Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10(Suppl 4):294-302.
9. Cassell GH, Waites KB, Crouse DT. Mycoplasmal infections. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1994:619-6.
10. Krause DC, Taylor-Robinson D. Mycoplasmas which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, eds. Mycoplasmas: molecular biology, and pathogenesis. Washington, DC: American Society for Microbiology, 1992:417-44.
11. Moller BR. The role of mycoplasmas in the upper genital tract of women. Sex Transm Dis 1983; 10(Suppl 4):281-4.
12. Thomsen AC. Occurrence of mycoplasmas in urinary tracts of patients with acute pyelonephritis. J Clin Microbiol 1978; 8:84-8.
13. Wang RY, Shih JW, Grandinetti T, et al. High frequency antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet 1992; 340:1312-6.
14. Wang RY, Shih JW, Weiss SH, et al. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis 1993; 17:724-9.
15. Wang RY, Grandinetti T, Shih JW, et al. Mycoplasma genitalium infection and host antibody immune response in patients infected by HIV, patients attending STD clinics and in healthy blood donors. FEMS Immunol Med Microbiol 1997; 19:237-45.
16. Lin JS. An antigenic analysis for membranes of Mycoplasma hominis by cross-absorption. J Gen Microbiol 1980; 116:187-93.
17. Brown MB, Minion FC, Davis JK, Pritchard DG, Cassell GH. Antigens of Mycoplasma hominis. Sex Transm Dis 1983; 10(Suppl 4):247-55.
18. Brown MB, Cassell GH, McCormack WM, Davis JK. Measurement of antibody to Mycoplasma hominis by an enzyme-linked immunoassay and detection of class-specific antibody responses in women with post-partum fever. Am J Obstet Gynecol 1987; 156:701-8.
19. Wang RY, Lo S-C. ELISA in human urogenital infections and AIDS. In: Tully J, Razin S, eds. Molecular and diagnostic procedures in mycoplasmology. Vol 2. New York: Academic Press, 1996:115-22.
20. Wise KS, Kim MF, Theiss PM, Lo S-C. A family of strain-variant surface lipoproteins of Mycoplasma fermentans. Infect Immun 1993; 61:3327-33.
21. Wang RY, Grandinetti T, Melcher G, et al. Seroconversion following Mycoplasma penetrans infections in patients with AIDS [abstract G-17]. In: Program and abstracts of the 93rd General Meeting of the American Society of Microbiology (Atlanta). Washington, DC: American Society for Microbiology, 1993: 142.
22. McCormack WM. Epidemiology of Mycoplasma hominis. Sex Transm Dis 1983; 10(Suppl 4):261-2.